Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients

Summary

The objective of this study is to assess the efficacy and safety of SOTB07 in asthma patients by observing changes FEV1 (% predicted) as the primary efficacy endpoint after oral administration of SOTB07 200mg, 400mg, placebo for 12 weeks.

Timeline

Start

2013-01

Primary completion

2015-10

Completion

—

Drugs

Indications